SLN — Silence Therapeutics plc
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1479615 ·
United Kingdom
Last close
$13.29
Market Cap
$826.03M
52W High
$17.58
52W Low
$5.88
ADV30
1,470,656
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 422,000 | 411,000 | -15,737,000 | -14,957,000 | 115,123,000 | 5,657,000 | 65,721,000 |
| Dec 2025 | 34,000 | 22,000 | -12,461,000 | -11,770,000 | 131,442,000 | 11,277,000 | 69,138,000 |
| Sep 2025 | 159,000 | 95,000 | -26,244,000 | -20,958,000 | 146,790,000 | 82,031,000 | 72,727,000 |
| Jun 2025 | 224,000 | 139,000 | -22,639,000 | -27,354,000 | 165,233,000 | 41,739,000 | 71,078,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-65,565,000
Investing CF
$6,389,000
Financing CF
$1,000
CapEx
$-110,768
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.95
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-577,526,000
Inventory
—
Receivables
$22,216,000
ST Investments
$64,421,000
EBIT TTM
$-77,081,000
Pretax Income TTM
$-75,028,000
Interest Exp TTM
—
Analysts
6
Yahoo Snapshot (yfinance, live)
Total Revenue
$615,000
EBITDA
$-63,942,000
Free Cash Flow
$-23,567,624
Enterprise Value
$555,021,440
Total Cash
$72,054,000
Total Debt
$112,000
Shares Out
62,154,086
Trailing EPS
$-1.29
Book Value
$0.81
ROE
-90.4%
ROA
-29.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 559,000 | -89,753,000 | -88,612,000 | 131,442,000 | 69,138,000 | — | -62,271,000 |
| Dec 2024 | 43,258,000 | -63,319,000 | -45,309,000 | 202,635,000 | 68,612,000 | — | -67,640,000 |
| Dec 2023 | 31,643,000 | -64,383,000 | -54,228,000 | 119,448,000 | 97,455,000 | — | -49,462,000 |
| Dec 2022 | 21,655,000 | -61,040,000 | -50,334,000 | 130,096,453 | 103,384,928 | — | -57,044,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.77
Max Pain — expiry 2026-09-18
max pain strike: $15.00 · spot: $13.29 · call oi: 8,019 · put oi: 7,902
Expected Move to 2026-09-18:
±$3.23
(24.27%) —
implied range
$10.06 –
$16.51
· ATM straddle on $12.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CYRX | Cryoport, Inc. | $827.61M | $16.34 | — |
| ANL | Adlai Nortye Ltd. | $831.68M | $14.16 | — |
| RIGL | RIGEL PHARMACEUTICALS INC | $834.63M | $45.11 | — |
| PHAR | Pharming Group N.V. | $811.12M | $11.46 | — |
| COLL | COLLEGIUM PHARMACEUTICAL, INC | $847.83M | $27.35 | — |
News headlines (Yahoo Finance, 1h cache)
Silence Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional ADSs
2026-08-14 20:55 · Yahoo
Silence Therapeutics Announces Pricing of Upsized $175 Million Underwritten Public Offering
2026-08-12 03:20 · Yahoo
Silence Therapeutics’ Divesiran Hits Phase II Goal, Sets Up Phase III PV Trial
2026-08-11 05:01 · Yahoo
Silence Therapeutics Announces Proposed Public Offering of $150 Million of American Depositary Shares
2026-08-10 20:01 · Yahoo
Silence Therapeutics Announces Positive Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera, Supporting its Potential Best-in-Class Profile
2026-08-10 11:30 · Yahoo
Silence Therapeutics Reports Second Quarter 2026 Financial and Business Results
2026-08-10 11:15 · Yahoo
Silence Therapeutics to Host Conference Call and Webcast to Discuss Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera
2026-08-09 21:00 · Yahoo
Silence Therapeutics plc (SLN) Initiated at Overweight as Analyst Highlights siRNA Pipeline Potential
2026-06-30 13:06 · Yahoo
Silence Therapeutics (SLN) Surges 26.0%: Is This an Indication of Further Gains?
2026-06-25 11:48 · Yahoo
How Silence Therapeutics (SLN) Is Building the Divesiran Case Around Fewer Blood Draws in Polycythemia Vera
2026-06-17 15:16 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.